Market Share of Global Artemisinin Combination Therapy Industry
The artemisinin combination therapy market is highly fragmented and consists of several major players. The major players on the international stage manufacture the majority of artemisinin combination therapy drugs. Market leaders with more funds for research and a better distribution system have established their positions in the market. Some of the global players are based in developed countries like the United States, the United Kingdom, France, Germany, and Japan. Some of the companies currently dominating the market are Cipla Inc., PLC, Novartis AG, Sanofi S.A., KPC Pharmaceuticals, and Shanghai Fosun Pharmaceutical Co., Ltd., among others.
Artemisinin Combination Therapy Market Leaders
Novartis AG
KPC Pharmaceuticals
Cipla Ltd.
Sanofi S.A.
Fosun Pharmaceutical (Guilin Pharmaceutical)
*Disclaimer: Major Players sorted in no particular order
